CX Institutional’s Medpace MEDP Stock Holding History

CX Institutional’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.85M	Hold	2,962	–	–	0.05%	264
2026 Q2	$1.57M	Sell	2,962 -1,390	-32%	-$642K	0.05%	282
2026 Q1	$2.09M	Sell	4,352 -91	-2%	-$46.6K	0.06%	246
2025 Q4	$2.5M	Hold	4,443	–	–	0.07%	182
2025 Q3	$2.28M	Hold	4,443	–	–	0.07%	195
2025 Q2	$1.39M	Buy	+4,443	New	+$1.33M	0.05%	225
2025 Q1	–	Sell	-833	Closed	-$277K	–	1206
2024 Q4	$277K	Hold	833	–	–	0.01%	458
2024 Q3	$278K	Hold	833	–	–	0.01%	479
2024 Q2	$343K	Buy	+833	New	+$330K	0.02%	429

Other funds holding MEDP

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return

McGuire Investment Group Wakefield, Rhode Island $1.12B AUM 57.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

CX Institutional's MEDP Position: Q3 2026 in Review

CX Institutional held its Medpace (MEDP) position steady in Q3 2026 at 2,962 shares worth $1.85M. The position accounts for 0.05% of the portfolio, ranked #264.

CX Institutional first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.5M in Q4 2025. 143 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

CX Institutional held 2,962 shares of Medpace worth $1.85M as of Q3 2026.
CX Institutional left its Medpace share count unchanged in Q3 2026.
Medpace made up 0.05% of CX Institutional's portfolio in Q3 2026, its #264 holding.
CX Institutional first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
CX Institutional's Medpace position peaked at $2.5M in Q4 2025.
143 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.